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EDITORIAL
Babylon  Towerr
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sTorre  da  Babilónia
.  .  .And  they  say:  ‘‘Come  on,  let’s  build  a  town  and  a  tower
reaching  heaven. .  .’’
Genesis  11,  1-9
In  most  Western  countries,  about  1%  of  the  population
dies  every  year.  Advances  in  medicine  have  greatly  improved
possibilities  to  effectively  treat  chronically  ill  patients  and
to  prolong  their  life.  There  is  increasing  recognition  that
extension  of  life  might  not  always  be  an  appropriate  goal
of  medicine.  End-of-Life  decisions  can  take  place  anywhere
patients  are  cared,  namely  in  hospitals,  nursing  homes,  hos-
pices  and  at  home.
COPD  is  the  5th  cause  of  mortality  and  will  rank  2nd  in
the  next  few  years.1 More  and  more  patients  are  placed  on
mechanical  ventilation  (MV).  Who  should  decide:  when  to
start  Palliative  and/or  End  of  Life  Care,  and  when  to  with-
draw  or  to  withhold  MV  and  End  of  Life  Care?
Deﬁnitions  are  important:  Palliative  Care  includes  any
intervention  aimed  to  prevent  and  relieve  suffering  by  con-
trolling  symptoms  and  providing  other  support  to  patients
and  families  in  order  to  maintain  and  improve  their  quality
of  life  during  all  stages  of  chronic  life-threatening  (or  end
stage)  illness.
End  of  Life  Care  is  the  care  (comfort,  supportive  or  symp-
tom  care)  provided  to  a  person  in  his/her  ﬁnal  stages  of
life.
It  is  difﬁcult  to  forecast  survival  time  of  COPD  patients.
End  stage  COPD  patients  undergoing  endo  tracheal  intuba-
tion  and  MV  suffer  from  bad  prognosis  and  difﬁcult  weaning,
due,  among  others  to  old  age,  muscle  wasting,  chronic
hypercapnia  and  hypoxia,  nutrition  problems,  use  of  sys-
temic  steroids  and  lack  of  mobility.2 Half  of  these  patients
will  die  in  hospital,  most  of  them  in  the  Intensive  Care
Unit  (ICU);  survivors  needing  prolonged  intensive  nursing  and
physiotherapy  complain  of  reduced  quality  of  life  as  a result
of  long  periods  of  hospitalization  or  tenancy  in  other  health
residences.Nevertheless  clinical  and  physiological  severity  of  COPD
cannot  be  the  main  determinant  of  End  of  Life  treatment
preferences.  That  is  why  doctors  should  not  argue  that  a
severe  health  status  may  induce  them  and/or  the  patient  to
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http://dx.doi.org/10.1016/j.rppneu.2014.04.001efuse  invasive  life  support.  Indeed  doctors  are  usually  less
ble  than  expected,  to  predict  real  life  expectancy,  and  have
ifﬁculty  in  identifying  low  prognosis  patients.3
In  this  issue  of  the  journal  Gaspar  et  al.4 report  the  results
f  a  national  survey  in  Portugal  on  the  attitude  of  pulmo-
ologists  toward  End  of  Life  Care  issues  in  COPD  patients.
he  main  message  of  this  survey  is  that  doctors  should
pend  more  time  to  speak  with  patients  and  relatives  to
nform  them  about  the  patient’s  prognosis  and  real  care  pos-
ibilities.  The  other  main  message  is  the  need  of  greater
wareness  of  properly  treating  (and  how)  the  symptoms,
rst  of  all,  dyspnea.
In  this  regard  it  is  surprising  that  even  at  medical
evel  there  is  unduly  concern  about  hypothetical  dangerous
ide  effects  of  treating  symptoms  such  as  dyspnea.  Indeed
pioids  in  lower  doses  are  not  associated  with  increased  hos-
ital  admissions  or  deaths  in  patients  receiving  long  term
xygen  therapy  for  COPD.5
Present  times  are  facing  changes  in  patient--doctor  rela-
ionship.  Final  decisions  on  care  are  not  only  up  to  doctors
nymore,  but  they  are  also  the  result  of  the  sum  of  different
iewpoints.  Doctors  and  other  allied  health  care  profession-
ls  seldom  share  the  same  view  on  the  prognosis.3 Relatives
ave  different  sources  of  information:  general  practitioner,
nternet,  and  TV  programs  (including  ﬁctions  like  E.R,  Doc-
or  House, etc.  which  usually  have  a  more  optimistic  view
f  medicine  possibilities,  including  somehow  immortality).6
eligious  vision  and  teaching  may  inﬂuence  decisions.  Legal
ssues  and  fears  are  more  and  more  main  determinants  in
nd  of  Life  decisions.  Availability  of  advanced  directives  is
ifferent  in  different  countries.  Health  system  organization
nd  facilities  as  a  result  of  Governments’  ﬁnancial  restraints
re  becoming  more  and  more  important  factors  in  decisions.
As  a  matter  of  fact  surrogate  decision  making  occurs  for
early  half  of  hospitalised  older  adults  and  includes  both
omplete  decision  making  by  the  surrogate  and  joint  deci-
ion  making  by  the  patient  and  surrogate  facing  a  broad
ange  of  decisions  in  the  ICU  and  the  hospital  ward  setting.7
evertheless  appropriate  decisions  need  appropriate  infor-
ation,  and  this  is  an  issue  requiring  improvement  in
nowledge  of  medical  and  health  care  allied  professionals.
gia.  Published  by  Elsevier  España,  S.L.  All  rights  reserved.
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Indeed  technical  progress  and  availability  of  machines
upporting  and  prolonging  life  may  result  in  ‘‘challenge  to
od’’  like  in  the  Babylon  Tower  Biblical  story.  The  challenge
s:  God  has  given  a  natural  history  to  illness,  machines  pro-
ong  this  story.  We  should  remember  that  the  ﬁnal  result  of
uch  a  challenge  was  the  complete  confusion  in  language.
 wonder  whether  all  professionals,  media  leaders  and
ealth  authorities  have  clear  in  mind  the  difference  among
are  withdrawing,  withholding  and  euthanasia  (words  are
mportant).
In  conclusion  refer  to  the  basic  ethical  principles  (i.e.
utonomy),  recognize  the  need  for  limiting  life  prolonging
reatments  such  as  mechanical  ventilation,  keep  the  family
otally  informed,  have  clear  in  mind  deﬁnitions,  do  not  be
‘afraid’’  of  the  double  effect  (i.e.  use  opioids),  and  improve
rganization  of  Palliative  Care.eferences
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